# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wells Fargo analyst Joseph O'Dea maintains Allegion (NYSE:ALLE) with a Equal-Weight and raises the price target from $17...
Barclays analyst Julian Mitchell maintains Allegion (NYSE:ALLE) with a Equal-Weight and raises the price target from $163 to...
Goldman Sachs analyst Joe Ritchie maintains Allegion (NYSE:ALLE) with a Buy and raises the price target from $176 to $198.
A look at the updated Berkshire Hathaway portfolio after the second quarter, including a new stake in UnitedHealth.